insights_auto
Why is INO up ११.५२%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.३६
arrow_upward
+११.५२%(+०.१४) 1D
नोभेम्बर ९, १०:११:५७ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.३०
High
US$ १.३९
Low
US$ १.२६
Mkt. cap
१३.९५ करोड
Avg. vol.
१.७४ करोड
Volume
५७.५२ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.३०
High
US$ १.३९
Low
US$ १.२६
Mkt. cap
१३.९५ करोड
Avg. vol.
१.७४ करोड
Volume
५७.५२ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Investing.com Canada
·
२ घण्टा पहिले
Form 8K Inovio Pharmaceuticals Inc For: 9 November By Investing.com
Quantisnow
·
२ घण्टा पहिले
INO: Inovio Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a...
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc